Angelini Pharma

EU Legislative Interests

- Regulation on Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency - Directive on the Union code relating to medicinal products for human use - Urban Wastewater Treatment Directive - Regulation of the European parliament and of the council laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795

Communication Activities

Headway is an initiative on Brain Health (incl. Mental Health and Epilepsy) conceived and launched in 2017 by the Think Tank The European House - Ambrosetti in partnership with Angelini Pharma, with the aim of creating a multidisciplinary platform for strategic reflection, analysis, dialogue and comparison between various European experiences in the management of individuals with mental and neurological disorders. The initiative keeps the trajectory and works in continuity and coherence with programs, activities and strategies of Governments and International Organizations (e.g., the WHO) and scientific societies / patient associations / advocacy groups (among others, Gamian Europe, EUFAMI, ILAE, IBE), as well as of European Institutions, with the objective of contributing to reducing the burden of Mental Health disorders and Epilepsy in Europe.

Interests Represented

Promotes their own interests or the collective interests of their members

Member Of

EUCOPE - European Confederation of Pharmaceutical Entrepreneurs Farmindustria Confindustria Dispositivi Medici APRE European Brain Council

Organisation Members

https://www.eucope.org/ https://www.farmindustria.it/ https://www.confindustriadm.it/ https://apre.it/ https://www.braincouncil.eu/about-us/partnerships/